BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19846970)

  • 1. Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
    Martín M; García-Sáenz JA; Maestro De las Casas ML; Vidaurreta M; Puente J; Veganzones S; Rodríguez-Lajusticia L; De la Orden V; Oliva B; De la Torre JC; López-Tarruella S; Casado A; Sastre J; Díaz-Rubio E
    Anticancer Res; 2009 Oct; 29(10):4185-7. PubMed ID: 19846970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
    Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
    Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
    Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
    Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
    Riethdorf S; Fritsche H; Müller V; Rau T; Schindlbeck C; Rack B; Janni W; Coith C; Beck K; Jänicke F; Jackson S; Gornet T; Cristofanilli M; Pantel K
    Clin Cancer Res; 2007 Feb; 13(3):920-8. PubMed ID: 17289886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
    Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
    J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.
    Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F
    Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
    Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
    Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
    Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B
    Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
    Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
    Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.
    Cristofanilli M; Hayes DF; Budd GT; Ellis MJ; Stopeck A; Reuben JM; Doyle GV; Matera J; Allard WJ; Miller MC; Fritsche HA; Hortobagyi GN; Terstappen LW
    J Clin Oncol; 2005 Mar; 23(7):1420-30. PubMed ID: 15735118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival.
    Hayes DF; Cristofanilli M; Budd GT; Ellis MJ; Stopeck A; Miller MC; Matera J; Allard WJ; Doyle GV; Terstappen LW
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4218-24. PubMed ID: 16857794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells in solid tumor in metastatic and localized stages.
    Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
    Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells in patients undergoing surgery for primary breast cancer: preliminary results of a pilot study.
    Biggers B; Knox S; Grant M; Kuhn J; Nemunatitis J; Fisher T; Lamont J
    Ann Surg Oncol; 2009 Apr; 16(4):969-71. PubMed ID: 19190965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.
    Tokudome N; Ito Y; Takahashi S; Kobayashi K; Taira S; Tsutsumi C; Oto M; Oba M; Inoue K; Kuwayama A; Masumura K; Nakayama Y; Watanabe C; Hatake K
    Breast Cancer; 2011 Jul; 18(3):195-202. PubMed ID: 21465230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer.
    Nakamura S; Yagata H; Ohno S; Yamaguchi H; Iwata H; Tsunoda N; Ito Y; Tokudome N; Toi M; Kuroi K; Suzuki E
    Breast Cancer; 2010 Jul; 17(3):199-204. PubMed ID: 19649686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
    Cristofanilli M
    Semin Oncol; 2006 Jun; 33(3 Suppl 9):S9-14. PubMed ID: 16797376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells in patients with breast cancer dormancy.
    Meng S; Tripathy D; Frenkel EP; Shete S; Naftalis EZ; Huth JF; Beitsch PD; Leitch M; Hoover S; Euhus D; Haley B; Morrison L; Fleming TP; Herlyn D; Terstappen LW; Fehm T; Tucker TF; Lane N; Wang J; Uhr JW
    Clin Cancer Res; 2004 Dec; 10(24):8152-62. PubMed ID: 15623589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
    Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
    Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.